Dual Stage Venous Cannulae
Sorin Group Italia S.R.L. · Decision date Oct 1, 2026
What did the FDA decide?
FDA records K263092 as a 510(k) premarket notification, with a decision dated Oct 1, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 1, 2026
Regulatory record facts
- Identifier
- K263092
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Sorin Group Italia S.R.L.
- Product code
- DWF
- Decision code
- SESE
- Decision date
- Oct 1, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass.
- Applicant
- Sorin Group Italia S.R.L.
- Product code
- DWF
- FDA device class
- 2
FDA decision timeline
K263092 received
Application receipt date recorded by FDA.
K263092 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code DWF
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
AngioVac F1885K263076 | AngioDynamics, Inc. | 510(k) clearance | Oct 30, 2026 | FDA |
DLP Coronary Ostial CannulaeK263596 | Medtronic, Inc. | 510(k) clearance | Oct 29, 2026 | FDA |
Tri Stage Venous CannulaeK262052 | Sorin Group Italia S.R.L. | 510(k) clearance | Sep 28, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Sorin Group Italia S.R.L.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Mirandola
Sources and methodology
- Original FDA record: K263092
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

